All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • [F-18]FlorastaminPhase 32 trials

    FutureChem · High Risk Prostate Carcinoma

  • 0.76% Na MFPPhase 32 trials

    Colgate Palmolive · Plaque, Gingivitis, Bacterial Load Reduction

  • 000 MG01Phase 32 trials

    Inmunotek S.L. · Rhinitis, Allergic, Rhinoconjunctivitis, Asthma, Allergic

  • 000 MM09Phase 32 trials

    Inmunotek S.L. · Rhinitis, Allergic, Rhinoconjunctivitis, Asthma, Allergic

  • 1.0% IP-001IP-001Phase 32 trials

    Immunophotonics, Inc. · Colorectal Cancer (CRC), Colon Cancer Liver Metastases, Rectal Cancer

  • 177Lu-edotreotide PRRT177Lu-DOTATOC, 177Lu-EdoPhase 32 trials

    ITM Solucin GmbH · Neuroendocrine Tumors

  • 177Lu-NYM032Phase 32 trials

    Norroy Bioscience Co., LTD · Prostate Cancer, Metastatic Castration-resistant Prostate Cancer

  • 2 NRTIsPhase 32 trials

    Merck & Co. · Human Immunodeficiency Virus (HIV) Infection, Infection, Human Immunodeficiency Virus, HIV Infections

  • 4-MUSTtrimebutine 4-methylumbelliferyl sulfatePhase 32 trials

    Valenta Pharm JSC · Chronic Cholecystitis, Biliary Dyskinesia

  • 6-Thio-2'-Deoxyguanosine6-thio-dG, THIOPhase 32 trials

    Maia Biotechnology · Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small -Cell Lung

  • 7MW3711Phase 32 trials

    Mabwell (Shanghai) Bioscience Co., Ltd. · Solid Tumor, Lung Squamous Cell Carcinoma

  • A166Phase 32 trials

    Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Her 2 Positive Breast Cancer, HER2-positive Breast Cancer

  • AAA817[225Ac]Ac-PSMA-617Phase 32 trials

    Novartis · Prostate Cancer

  • AAV2-hRPE65v2voretigene neparvovec-rzylPhase 32 trials

    Roche (Genentech) · Leber Congenital Amaurosis, Inherited Retinal Dystrophy Due to RPE65 Mutations

  • ABBV-722Phase 32 trials

    AbbVie · Rheumatoid Arthritis, Systemic Sclerosis

  • ABC3TC STR, 3TC immediate releasePhase 32 trials

    GSK · HIV Infections

  • ABO1108Phase 32 trials

    Suzhou Abogen Biosciences Co., Ltd. · Varicella-zoster Virus

  • ABP 206Phase 32 trials

    Amgen · Melanoma

  • ABP 234Phase 32 trials

    Amgen · Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC), Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

  • ABP-671Phase 32 trials

    Atom Therapeutics Co., Ltd · Chronic Kidney Disease, Gout

  • AcotiamideItopride HydrochloridePhase 32 trials

    Getz Pharma · Postprandial Distress Syndrome, Functional Dyspepsia

  • Shanghai Haiyan Pharmaceutical Technology Co., Ltd. · Pain

  • ADSTEM Inj.Phase 32 trials

    EHL Bio Co., Ltd. · Atopic Dermatitis

  • AfimetoranBMS-986256, BLN-256Phase 32 trials

    Beeline Medicines Corporation · Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus (CLE), Systematic Lupus Erythematosus

  • AGN-151586Phase 32 trials

    AbbVie · Forehead Lines, Glabellar Lines

  • AGTC-501rAAV2tYF-GRK1-hRPGRco, and modified corticosteroidPhase 32 trials

    Beacon Therapeutics · X-Linked Retinitis Pigmentosa

  • AK111Phase 32 trials

    Akeso · Psoriasis, Skin Diseases, Ankylosing Spondylitis

  • allo-APZ2-CVUSkin-derived ABCB5-positive dermal mesenchymal stromal cellsPhase 32 trials

    RHEACELL GmbH & Co. KG · Venous Leg Ulcer, Skin Ulcer Venous Stasis Chronic

  • allo-APZ2-OTSPhase 32 trials

    RHEACELL GmbH & Co. KG · Epidermolysis Bullosa

  • AmlenetugLu AF82422Phase 32 trials

    H. Lundbeck A/S · Multiple System Atrophy

  • AMX0035Phase 32 trials

    Amylyx Pharmaceuticals Inc. · Wolfram Syndrome, Progressive Supranuclear Palsy, PSP

  • and dexamethasonePhase 32 trials

    AstraZeneca · AL Amyloidosis

  • AndecaliximabPhase 32 trials

    Ashibio Inc · Fibrodysplasia Ossificans Progressiva, Heterotopic Ossification (HO)

  • AnselamimabCAEL-101Phase 32 trials

    AstraZeneca · AL Amyloidosis

  • anzutresgene autoleucelIMA203 Product, IMA203 product- flat dosePhase 32 trials

    Immatics US, Inc. · Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult

  • AP301Solnatide for reconstitution for forPhase 32 trials

    Alebund Pharmaceuticals · Hyperphosphatemia, Chronic Kidney Disease, Receiving Dialysis, ESRD (End-Stage Renal Disease)

  • ApraglutidePhase 32 trials

    VectivBio AG · Short Bowel Syndrome (SBS), SBS Associated With Intestinal Failure (SBS-IF), Short Bowel Syndrome

  • ARDTPhase 32 trials

    Novartis · Metastatic Castration-Resistant Prostate Cancer (mCRPC), Prostatic Neoplasms

  • Arlocabtagene AutoleucelBMS-986393, GPRC5D CAR T cellsPhase 32 trials

    Bristol Myers Squibb · Multiple Myeloma, Relapsed or Refractory Multiple Myeloma (RRMM)

  • ARPI: EnzalutamideARPI abirateronePhase 32 trials

    Novartis · Metastatic Castration Resistant Prostate Cancer (mCRPC), Prostate Cancer

  • ARTPhase 32 trials

    GSK · HIV Infections, HIV-1 Infection

  • ASC40Phase 32 trials

    Ascletis Pharmaceuticals Co., Ltd. · Acne

  • ASKC202Phase 32 trials

    Jiangsu Aosaikang Pharmaceutical Co., Ltd. · EGFR Activating Mutation, Non-Squamous Non-Small Cell Lung Cancer (NSCLC), MET Positive

  • AST-001Phase 32 trials

    Ascentawits Pharmaceuticals, Ltd · Solid Tumor, Pancreatic Cancer, Autism Spectrum Disorder

  • AT-001NACA, NAC-amidPhase 32 trials

    Arctic Therapeutics · Hereditary Cystatin C Amyloid Angiopathy (HCCAA), Hemorrhage Brain, Hemorrhage Cerebral

  • ATG-022Phase 32 trials

    Antengene Biologics Limited · Advanced Gastric or Gastroesophageal Junction Adenocarcinoma, Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

  • ATYR1923KRP-R120, EfzofitimodPhase 32 trials

    aTyr Pharma, Inc. · Interstitial Lung Disease, Pulmonary Sarcoidosis

  • AU-011Bel-sarPhase 32 trials

    Aura Biosciences · Choroidal Melanoma, Indeterminate Lesions, Uveal Melanoma

  • AVTX-803L-FucosePhase 32 trials

    AUG Therapeutics · Leukocyte Adhesion Deficiency

  • AXS-14EsreboxetinePhase 32 trials

    Axsome Therapeutics, Inc. · Fibromyalgia

NewerPage 12 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.